Roche Diagnostics has introduced a battery of Stat immunoassays for cardiac biomarker testing on a Cobas 6000 analyser, an integrated system for diagnostic labs with medium testing volumes.
With a nine-minute duration, the assays enable labs to deliver results to doctors treating cardiac patients in about half the time of standard Roche tests.
The tests complement a line of existing Stat cardiac assays for Roche's stand-alone platform, the Cobas 4000 series.
'In critical care environments that require rapid decision making, this line of Stat assays can help healthcare facilities meet current cardiac care turnaround time guidelines,' said Hans-Juergen Loyda, director of clinical development and education at Roche Diagnostics.
'Making the tests available on the Cobas 6000 series gives labs the option to run Roche Stat assays on either stand-alone or integrated platforms,' he added.
The nine-minute Stat immunoassay tests include troponin T, troponin I, CK-MB, myoglobin and NT-proBNP and run on the Cobas E 601 analyser, part of the Cobas 6000 analyser series, an integrated platform that offers both clinical chemistry and immunoassay testing.
The Stat tests are virtually equivalent to Roche's 18-minute tests in performance, precision and sensitivity.
The cardiac Stat assays can all be run with one simple blood draw via the Roche Onetube solution, which consists of a single lithium heparin tube that can be run on any of Roche's integrated platforms.
By allowing a single technician to process a single draw from a single point of entry instead of drawing multiple tubes for cardiac tests on multiple analysers, the Onetube helps to simplify sample handling and reduces the need for sample splitting.
